A new search tool unveiled Friday increases public access to information about the connections between advisors to the ...
For example, developing a drug nowadays takes eight to ten years and costs over $2bn, yet less than 10% of clinical ...
The use of AI in drug discovery and development has been recognised, explored, and implemented throughout the last decade, ...
Clinical Trials Arena on MSN1d
Funding drought: how can biotech and biopharma keep trials running?Biotech and biopharma companies have battled with a drought of private investment in recent years but could now face government funding cuts.
Shore Capital, which covers hVIVO, sees plenty of upside. The broker notes that the company’s cash generation, revenue ...
Innate Pharma continues its slow rollout of promising clinical candidates, with 2025 set for key milestones. Read more about ...
American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma ...
Today, there is now reliable evidence that digitally enabled trials provide value and can solve some of the most chronic ...
Most individuals diagnosed with a rare disease won’t live to become teenagers or adults. I knew what I had to do.
Psychiatry was once big business for pharma, with drugs like Prozac making billions. Now a few breakthroughs are reviving ...
it could lead to the next big medical breakthrough. Yet… The biggest barrier to bringing new drugs to market isn’t discovery; it’s clinical trials. It takes hundreds of millions of dollars ...
The pharma giant announced a new partnership with BridGene Biosciences that will use its IMTAC platform for drug discovery.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback